反流性食管炎的外治疗法效果探讨

Discussion on the Effect of External Therapy for Reflux Esophagitis

摘要: 反流性食管炎(Reflux Wsophagitis, RE)已逐渐发展成一种常见的消化道病症，其全球和国内的发病率均非常高。据统计，西方国家中大约有7%~15%的人口患有此种症状，而在中国则大概是7%~8%的比例。这种状况对患者的健康和生活品质造成了极大的威胁，因为它可能引发一系列并发的胃肠道问题，如上消化道出血、Barrett食管、食管溃疡与食管狭窄等，严重时该病甚至会进展为食管腺癌。此外，一些更极端的情况可能会引起诸如支气管哮喘或阻塞性睡眠呼吸暂停综合征等症状，从而进一步降低了患者的生活质量。根据西医学界的研究成果，质子泵抑制剂作为首选疗法，但这类药品也面临着诸多副 作用、疗效短暂且费用较高的挑战。本文主要基于国内相关最新研究进展，对如何减低反流性食管炎的复发率进行深刻讨论。

Abstract: At present, reflux esophagitis (RE) has gradually developed into a common digestive tract disease, with a very high incidence rate both globally and domestically. According to statistics, approximately 7% to 15% of the population in Western countries suffer from this condition, while in China, the proportion is roughly 7% to 8%. This situation poses a significant threat to patients’ health and quality of life as it may lead to a series of concurrent gastrointestinal problems, such as upper gastrointestinal bleeding, Barrett’s esophagus, esophageal ulcers, and esophageal stenosis. In severe cases, the disease may even progress to esophageal adenocarcinoma. Moreover, some more extreme cases may cause symptoms such as bronchial asthma or obstructive sleep apnea syndrome, further reducing the patients’ quality of life. According to the research results of the Western medical community, proton pump inhibitors are considered the first choice of treatment, but these drugs also face many challenges such as numerous side effects, short-term efficacy, and high costs. This article mainly discusses the latest domestic research progress on how to reduce the recurrence rate of reflux esophagitis.